expert perspectives

in Prostate Cancer

Expert Perspectives in Prostate Cancer to Cover Key Topics in Prostate Cancer Treatment

Overview

Expert Perspectives delivers health care providers with insights from key thought leaders on the latest advancements and current practices in medicine, in a concise and timely format. This issue of Expert Perspectives in Prostate Cancer will feature selected topics in Prostate Cancer that we hope you will find of value in your clinical practice.

The clinicians who were surveyed selected the following experts and topics.

Community-Selected Experts: 

Tanya B. Dorff, MD

Associate Professor, Department of Medical Oncology & Therapeutics Research
Section Chief, Genitourinary Disease Program
City of Hope
Duarte, CA

Robert Dreicer, MD, MS, MACP, FASCO

Section Head, Medical Oncology
Deputy Director, University of Virginia Comprehensive Cancer Center
Associate Director for Clinical Research
Co-Director, Paul Mellon Urologic Cancer Institute
Professor of Medicine and Urology
University of Virginia School of Medicine
Charlottesville, VA

Neal D. Shore, MD, FACS

Director, CPI, Carolina Urologic Research Center
Chief Medical Officer, Urology/Surgical Oncology
GenesisCare, US
Myrtle Beach, SC

Community-Selected Topics:

Expert Roundtables 

    Combinatorial Strategies in Targeting Metastatic Castration-Resistant Prostate Cancer
    High-Risk Prostate Cancer: Implications of Entering a More Molecular, More Genomic Era
    Prostate Cancer: Avoiding Overtreatment and Undertreatment in the Current Era
    Therapeutic Sequencing in View of Prostate Cancer Biology


Clinical Topic Updates 

    Co-Inhibition and Co-Targeting in Advanced Prostate Cancer
    Next-Generation Imaging and Curative-Intent Metastasis-Directed Therapies
    Noninvasive Profiling of Advanced Prostate Cancer
    Prostate-Specific Membrane Antigen–Positive Metastatic Castration-Resistant Prostate Cancer


Patient Care Perspectives 

    Adherence to Oral Therapies for Advanced Prostate Cancer
    Clinical Trial Design Innovation and Incorporation of Patient Views
    Novel Antiandrogens and Treatment Intensification for Prostate Cancer
    Quality-Adjusted Survival in Metastatic Castration-Resistant Prostate Cancer

More in Prostate Cancer

Thumb

Prostate Cancer

Identifying the High-Risk Patient: Prognostic Markers in Advanced Prostate Cancer

Expert Roundtables by Glen Gejerman, MD, Daniel J. George, MD, William K. Oh, MD, and Neal D. Shore, MD, FACS

Although the incidence of metastatic prostate cancer decreased with the introduction of PSA-based screening, prostate cancer will still be responsi...READ MORE

Thumb

Prostate Cancer

Newer PET/CT Imaging Techniques Promise to Improve Detection of Metastatic Prostate Cancer

Patient Care Perspectives by Peter R. Carroll, MD, MPH, Neal D. Shore, MD, FACS

The question of defining metastatic disease with available imaging techniques is an important one. Globally, current standard imaging techniques in...READ MORE

Thumb

Prostate Cancer

Newer Options for Osseous Metastases in Advanced Prostate Cancer

Clinical Topic Updates by Daniel J. George, MD, Neal D. Shore, MD, FACS

As with other epithelial cancers, metastasis to the bone is a sentinel event in the development of advanced prostate cancer. The bone microenvironm...READ MORE

More In Oncology

MDS & AML

High Risk Mds: Investigating Novel Combination Therapies

Clinical Topic Updates by Rami S. Komrokji, MD

MDS & AML

Improving Access To Care For Patients With Mds

Patient Care Perspectives by Rami S. Komrokji, MD

MDS & AML

Maintenance Therapy Post Allogeneic Stem Cell Transplantation In High Risk Mds And Aml

Clinical Study Insights by Andrew M. Brunner, MD